Cytokinetics Announces Board and Executive Changes
Ticker: CYTK · Form: 8-K · Filed: Dec 16, 2024 · CIK: 1061983
| Field | Detail |
|---|---|
| Company | Cytokinetics Inc (CYTK) |
| Form Type | 8-K |
| Filed Date | Dec 16, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, executive-compensation, governance
Related Tickers: CYTK
TL;DR
Cytokinetics filed an 8-K on 12/16/24 for board/exec changes. Details TBD.
AI Summary
On December 16, 2024, Cytokinetics, Incorporated filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates the election of new directors and potential adjustments to compensatory arrangements for certain officers, though specific details on dollar amounts or new appointments are not provided in this excerpt.
Why It Matters
Changes in a company's board of directors and executive compensation can signal shifts in strategy, governance, or future performance expectations.
Risk Assessment
Risk Level: medium — Changes in board composition and executive compensation can indicate internal shifts that may impact future company performance and strategy.
Key Numbers
- 000-50633 — SEC File Number (Identifies Cytokinetics' filings with the SEC.)
- 94-3291317 — IRS Employer Identification No. (Tax identification number for Cytokinetics.)
Key Players & Entities
- Cytokinetics, Incorporated (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- South San Francisco, California (location) — Principal Executive Offices
FAQ
What specific changes were made to the board of directors?
The filing indicates the election of directors, but the specific names and number of directors elected are not detailed in this excerpt.
Are there any new executive officers appointed?
The filing mentions 'Appointment of Certain Officers' and 'Compensatory Arrangements of Certain Officers,' suggesting potential changes, but does not name specific individuals or roles.
What is the date of the earliest event reported in this 8-K?
The earliest event reported is December 16, 2024.
What is Cytokinetics' principal executive office address?
Cytokinetics' principal executive offices are located at 350 Oyster Point Boulevard, South San Francisco, California, 94080.
What is the SIC code for Cytokinetics?
The Standard Industrial Classification (SIC) code for Cytokinetics is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 668 words · 3 min read · ~2 pages · Grade level 11.5 · Accepted 2024-12-16 16:38:08
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value CYTK The Nasdaq Global Se
Filing Documents
- cytk-20241216.htm (8-K) — 38KB
- 0000950170-24-136695.txt ( ) — 149KB
- cytk-20241216.xsd (EX-101.SCH) — 24KB
- cytk-20241216_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CYTOKINETICS, INCORPORATED Date: December 16, 2024 By: /s/ John O. Faurescu John O. Faurescu, Vice President, Associate General Counsel & Secretary